Prelude Capital Management, LLC Spring Works Therapeutics, Inc. Transaction History
Prelude Capital Management, LLC
- $1.5 Billion
- Q4 2024
A detailed history of Prelude Capital Management, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 16,437 shares of SWTX stock, worth $796,208. This represents 0.04% of its overall portfolio holdings.
Number of Shares
16,437
Previous 44,493
63.06%
Holding current value
$796,208
Previous $1.43 Million
58.39%
% of portfolio
0.04%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$347 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$272 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$168 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$159 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$145 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.02B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...